They also examined the effects of APOL1 variants on the progression of hypertension‐induced CKD in large cohorts of black and white patients with CKD attributed to hypertension (Foster et al., 2013; Parsa et al., 2013). This evidence concerns the gene APOL1 and chronic kidney disease.